Lettmann Jason sold ALXO
March 19, 2026 · Form 4 insider transaction
Lettmann Jason sold 12,311 shares of ALX Oncology Holdings Inc. at $2.17 per share, a transaction worth $26.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,311
Price
$2.17
Total value
$26.7K
InsiderLettmann Jason
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 19, 2026
Filing dateMarch 23, 2026
Shares owned after293,609
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of perfomance-based restricted stock units.